Chinese Diagnostic Imaging Market to Reach a Value of More Than $2.5 Billion by 2016
<0> Decision Resources GroupChristopher Comfort, 781-993-2597orMillennium Research GroupAlex Jablokow, 617-599-8613 </0>
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the Chinese government’s large investment in bridging the gap in healthcare quality between rural and urban hospitals will be the largest driver of growth in the Chinese diagnostic imaging market. Domestic competitors will maintain a strong presence, particularly in lower-end X-ray and ultrasound systems, while consumer preference for known brand names will support sales by multinational manufacturers. The overall Chinese diagnostic imaging market will grow modestly to reach a value of more than $2.5 billion by 2016.
As part of the Chinese government’s $125 billion New Medical Reform Plan, intended to provide affordable healthcare to the entire population by 2020, it will invest money to upgrade lower-tier rural hospitals, as well as constructing new facilities. As a result, higher-tier hospitals will be able to replace their outdated systems, while smaller, less affluent hospitals will be able to purchase systems for the first time, particularly more advanced diagnostic imaging systems such as computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine systems. This will represent a significant sales opportunity for manufacturers of such systems.
Domestic competitors have a significant role in the market for analog X-ray and lower-end ultrasound systems. They have relatively lower production costs than multinationals. The large number of such domestic competitors keep prices for these systems low, which makes them attractive for less-affluent hospitals and clinics. In 2011 Beijing Wandong Medical Equipment was the overall leader among domestic competitors.
Each of the top three multinational competitors in China, GE Healthcare, Siemens Healthcare and Philips Healthcare, has shares in each of the market’s segments: MRI, CT, X-ray, ultrasound and nuclear medicine. As a result, they can leverage their position to raise brand awareness and establish strong customer relationships. Wealthy urban Chinese show a strong preference for known international brands, and this influences hospital system purchases.
“The Chinese government also has an implementation initiative for positron emission tomography (PET)/CT systems,” said MRG Analyst Michelle Chan. “They plan to increase licensing and install many new PET/CT systems by 2016. This initiative will initially be limited by the need to establish a radiopharmaceutical supply chain. Once that infrastructure is in place, we can expect to see a rapid increase in sales, probably by 2015.”
Millennium Research Group’s report includes unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for MRI, CT, X-ray, ultrasound and nuclear medicine systems in China.
Millennium Research Group (), a Decision Resources Group company (), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at .